Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Legend Biotech Corp (LEGN US)
Watchlist
78
Analysis
Health Care
•
China
Legend Biotech Corporation operates as a biopharmaceutical company. The Company engages in discovery and development of novel cell therapies for oncology and other indications. Legend Biotech serves customers in the State of New Jersey.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Thematic (Sector/Industry)
•
23 Dec 2022 14:05
2022 in Rear Mirror View: Top Performers From My Global Healthcare Coverage Universe
From my coverage universe, two Taiwanese stocks generated 59% and 71% returns in nearly six months. New product launch and geography expansion are...
Tina Banerjee
Follow
688 Views
Share
bullish
•
Akeso Biopharma Inc
•
13 Dec 2022 08:50
Akeso Biopharma (9926.HK) - Behind the Deal with Summit: A Snake Swallows an Elephant?
The deal between Akeso and Summit set a new record of China license-out. We deep dive the logic of the deal. Investors are advised not to neglect...
Xinyao (Criss) Wang
Follow
393 Views
Share
bearish
•
Thematic (Sector/Industry)
•
09 Oct 2022 08:58
China Healthcare Weekly (Oct.7)- Biotech Accept Reality, Import Substitution Logic, Consumer Medical
Although unwilling, biotech will face the harshest truth in 2023; Import substitution isn't good logic. Investors should know "when to join" &...
Xinyao (Criss) Wang
Follow
251 Views
Share
bullish
•
Genscript Biotech
•
14 Sep 2022 08:47
Genscript Biotech (1548.HK) 22H1 - The Outlook and the Risks Behind
If seen from the business level, GenScript has investment value,with high growth potential in valuation. The biggest worry is "black swan event"....
Xinyao (Criss) Wang
Follow
218 Views
Share
bearish
•
Thematic (Sector/Industry)
•
31 Jul 2022 09:26
China Healthcare Weekly (July.29)-Subsidy for VBP, Unpredictable NMPA, Ways for Internationalization
The policy about subsidy for VBP is a positive sign for innovation. NMPA is unpredictable, increasing the uncertainty of drug approval. Here's what...
Xinyao (Criss) Wang
Follow
256 Views
Share
First
Previous
3
4
5
6
7
8
9
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.32.1
x